NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) shares surpassed their 200-day moving average at C$4.84, trading as high as C$4.91 during recent trading, ultimately closing at C$4.87.
• The company reports a debt-to-equity ratio of 129.42, and has a market capitalization of C$1.20 billion but a negative P/E ratio of -3.06.
• NorthWest Healthcare Properties REIT offers investors a portfolio of high-quality healthcare real estate across markets including Australasia, Brazil, Germany, and Canada.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - ) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$4.84 and traded as high as C$4.91. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.87, with a volume of 547,924 shares traded.

NorthWest Health Prop Real Est Inv Trust Trading Down 0.6%

The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The firm's 50-day simple moving average is C$4.92 and its 200 day simple moving average is C$4.84. The stock has a market capitalization of C$1.20 billion, a P/E ratio of -3.06, a PEG ratio of 0.74 and a beta of 1.05.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.